-
-
30/01/2025 31/01/2025 America/Toronto Pathways To Access & Reimbursement Pathways To Access & Reimbursement
January 30 – 31, 2025
One King West Hotel, Toronto, ON
Please visit https://www.canadianinstitute.com/pathways-access-reimbursement/ for more information and updates. One King West Hotel, Toronto, ON true DD/MM/YYYY 1440 use-title -
-
-
30/01/2025 31/01/2025 America/Toronto Pathways To Access & Reimbursement Pathways To Access & Reimbursement
January 30 – 31, 2025
One King West Hotel, Toronto, ON
Please visit https://www.canadianinstitute.com/pathways-access-reimbursement/ for more information and updates. One King West Hotel, Toronto, ON true DD/MM/YYYY 1440 use-title -
Celebrating a Decade of Collaborative Conversations on Market Access and Reimbursement
10th Anniversary Specials
10 Years
in Review
Join key stakeholders from across Canada’s pharmaceutical and health care sector, reflecting on the polices and initiatives that have shaped the innovation ecosystem and impacted patient access in Canada.
Anniversary
Champagne Toast
Join us for a special prosecco pour, as we raise a glass to 10 years of collaboration, and network with your peers in a post-Day One reception.
Interactive
Sessions
Join smaller-groups discussions on data gaps and how patient experiences and insights can support and solve challenges along the pathways to access.
CONFERENCE CO-CHAIRS
Andrea Masters
Strategic Access & Pricing Director
Hoffmann-La Roche Limited
Rebecca Vieira
Head of Access and Pricing
Vertex Pharmaceuticals
Distinguished Faculty
Gail Attara
President
Gastrointestinal Society
Tara Cowling
President
Medlior
Julie Frappier
President & Founder, TOWWERS Program
Data4Actions
Guillaume Couillard
Executive Director
PMPRB
Alex Chambers
Senior Market Access Manager
Bayer Inc.
Mina Tadrous
Assistant Professor, Leslie Dan Faculty of Pharmacy
University of Toronto
Featuring Key Topics
Pharmaceutical Policy Power Panel: Hear reflections and projections on the evolution of Canada’s pharmaceutical access environment so that you can plan for 2025 and beyond
Technology Use Cases for Pharma: Examine practical applications for managing market access and drug negotiations
Hypothetical Case Study and Breakout Discussion: Identify opportunities to improve the drug to market process through patient inclusivity
Working Group on how to advance the use of value-based agreements in Canada
About the conference
The Canadian pharmaceutical market is undergoing significant transformation. CADTH has evolved into Canada’s Drug Agency (CDA), the pCPA has transitioned into a standalone entity, and federal policies are advancing with funding for drugs for rare diseases and progress on the pharmacare file. Meanwhile, the PMPRB has resumed consultations on final guidelines for drug pricing reviews, adding further complexity to an already dynamic landscape.
CI’s Forum on Pathways to Access & Reimbursement provides a critical platform for stakeholders—government, pharmaceutical manufacturers, patients, and payers—to engage in meaningful discussions on market access, drug price regulation and drug reimbursement. This is your opportunity to explore innovative approaches to ensure patient access to the right drug at the right time.
As in years prior, the 2025 program is curated to ensure that you start the new year with a clear view of Canada’s pharmaceutical landscape. It will put a strong focus on evidence generation, value-based decision-making, expedited pathways to access, and patient perspectives.
Why Attend
BUILD a market access and drug pricing plan based on insights from CDA, INESSS, patients, and industry leaders
PREPARE for PMPRB’s impending draft guidelines for drug pricing review
ALIGN drugs submissions with payer priorities
DEVELOP an understanding of how to use AI and digital tools to support market access
COLLABORATE with the life sciences community on strategies to improve the collection and use of RWE for drug access decisions
WHO YOU WILL MEET
Practitioners at every level with experience in:
- Pricing
- Reimbursement
- Market access
- Patient access
- Government and regulatory affairs
- Health economics
- Research and development
- Policy and compliance
- Pharmacy services
- Marketing
- National trade
- Formularies
- Business development
- Sales
From brand generic and manufacturing companies involved in:
- Product development
- Public drug programs
- Pharmaceutical benefits
- Pharmaceutical strategy
- Drug submissions
- Formulary management
- Policy and economic analysis
- Provider services and
- relations
- Pharmacy
And representatives from:
- Associations
- Patient Advocacy Groups
Testimonials
Great overview, gave me a different perspective. Got me thinking differently.
I liked the quality of the speakers.
Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.
Related Conferences
